This study provides insights linking DNA methylation and inflammasome activation in atherosclerosis and also provides the potential for developing new therapeutics by targeting DNMT and inflammasomes for the treatment of atherosclerosis as well as other inflammatory diseases. Here, DNMT1 is linked to atherosclerosis.